WIGGANS THOMAS G

SEC Form 4 insider trading activity

WIGGANS THOMAS G has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2025.

On the most recent filing, WIGGANS THOMAS G is listed as Director at Jasper Therapeutics, Inc. Inside the rolling window, WIGGANS THOMAS G reported 1 open-market purchase totaling $100K in JSPR and no open-market sales.

Companies traded

Other insiders at JSPR

Insider Buying

$100K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
JSPR
WIGGANS THOMAS G
Purchase$100KSep 24SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has WIGGANS THOMAS G made?

WIGGANS THOMAS G has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.

Which companies does WIGGANS THOMAS G trade?

WIGGANS THOMAS G has filed SEC Form 4 disclosures for 1 company, including JSPR.

When was WIGGANS THOMAS G's most recent SEC Form 4 filing?

WIGGANS THOMAS G's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2025.

What is WIGGANS THOMAS G's total buy and sell value in the current window?

Inside the rolling retention window, WIGGANS THOMAS G bought $100K and sold $0 based on SEC Form 4 filings.

What was WIGGANS THOMAS G's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 41,000 JSPR shares on 2025-09-22, worth $100K, per SEC Form 4 filings.